A detailed history of Acadian Asset Management LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 718 shares of AMPH stock, worth $29,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares
718
Holding current value
$29,323
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.99 - $50.09 $26,558 - $35,964
718 New
718 $34,000
Q4 2022

Feb 14, 2023

SELL
$27.93 - $31.27 $2.33 Million - $2.6 Million
-83,303 Reduced 77.73%
23,870 $668,000
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $594,221 - $813,927
-21,561 Reduced 16.75%
107,173 $3.01 Million
Q2 2022

Aug 09, 2022

BUY
$29.79 - $42.29 $553,676 - $786,001
18,586 Added 16.87%
128,734 $4.48 Million
Q1 2022

May 12, 2022

BUY
$22.96 - $36.45 $2 Million - $3.18 Million
87,113 Added 378.18%
110,148 $3.95 Million
Q4 2021

Feb 10, 2022

BUY
$18.14 - $23.29 $82,228 - $105,573
4,533 Added 24.5%
23,035 $534,000
Q3 2021

Nov 12, 2021

SELL
$17.83 - $21.49 $1.44 Million - $1.74 Million
-80,933 Reduced 81.39%
18,502 $350,000
Q2 2021

Aug 11, 2021

BUY
$17.11 - $20.92 $1.49 Million - $1.82 Million
86,816 Added 687.98%
99,435 $2 Million
Q1 2021

May 11, 2021

BUY
$17.21 - $20.65 $121,588 - $145,892
7,065 Added 127.21%
12,619 $231,000
Q4 2020

Feb 11, 2021

SELL
$17.76 - $21.24 $215,215 - $257,386
-12,118 Reduced 68.57%
5,554 $112,000
Q3 2020

Nov 09, 2020

SELL
$17.99 - $22.22 $197,224 - $243,597
-10,963 Reduced 38.29%
17,672 $331,000
Q2 2020

Aug 12, 2020

BUY
$14.25 - $22.46 $408,048 - $643,142
28,635 New
28,635 $642,000
Q1 2020

May 11, 2020

SELL
$12.66 - $20.08 $64,262 - $101,926
-5,076 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$17.07 - $20.64 $591,253 - $714,907
-34,637 Reduced 87.22%
5,076 $98,000
Q3 2019

Nov 07, 2019

BUY
$19.12 - $22.62 $679,008 - $803,304
35,513 Added 845.55%
39,713 $788,000
Q2 2019

Aug 08, 2019

BUY
$18.92 - $22.96 $79,464 - $96,432
4,200 New
4,200 $88,000
Q1 2019

May 09, 2019

SELL
$19.46 - $25.28 $62,310 - $80,946
-3,202 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$17.72 - $22.51 $56,739 - $72,077
3,202 New
3,202 $63,000
Q3 2018

Oct 30, 2018

SELL
$15.39 - $19.38 $305,352 - $384,518
-19,841 Closed
0 $0
Q2 2018

Jul 24, 2018

SELL
$14.63 - $19.6 $2.17 Million - $2.91 Million
-148,243 Reduced 88.2%
19,841 $302,000
Q1 2018

Apr 12, 2018

SELL
$17.23 - $20.35 $54,756 - $64,672
-3,178 Reduced 1.86%
168,084 $3.15 Million
Q4 2017

Jan 18, 2018

SELL
$17.76 - $19.75 $417,981 - $464,816
-23,535 Reduced 12.08%
171,262 $3.3 Million
Q3 2017

Oct 13, 2017

BUY
$14.73 - $17.99 $2.87 Million - $3.5 Million
194,797
194,797 $3.48 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.